PerkinElmer, Inc. Appoints Karl Hecker To Head Key Research & Development Center

PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions, today announced its appointment of Dr. Karl Hecker as Director of Research & Development (R&D) for its Boston-based Center of Excellence. He will lead all product R&D efforts for the Center, which focuses on molecular medicine solutions for the company's Life and Analytical Sciences unit. These solutions include chemistries, reagents, instruments and software serving the needs of customers engaged in areas such as proteomics, genomics and life sciences research.

Back to news